Alimera Sciences to Present at the Zooming with LD Micro Virtual Conference on April 15, 2021

Rhea-AI Summary

Alimera Sciences (Nasdaq: ALIM) announced that Rick Eiswirth, President and CEO, will present at the Zooming with LD Micro virtual conference on April 15, 2021, at 11:00 AM ET. The event will include a live Q&A session and offers registered investors opportunities for one-on-one meetings. Alimera focuses on developing prescription ophthalmic treatments for retinal diseases, addressing significant unmet medical needs in aging populations. For more details, visit www.alimerasciences.com.

ATLANTA, April 09, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, today announced that Rick Eiswirth, President and Chief Executive Officer, will give a corporate presentation at the Zooming with LD Micro virtual conference on Thursday, April 15, 2021 at 11:00 AM ET followed by a live Q&A session with registered investors and other conference attendees. In addition, Mr. Eiswirth will be available for virtual one-on-one meetings the same day.

Registration link: https://us02web.zoom.us/webinar/register/WN_AnmlPmPwSHGD5rRTJtxp6w

About Alimera Sciences, Inc.

Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations. For more information, please visit www.alimerasciences.com.

For press inquiries: Jules Abraham for Alimera Sciences 917-885-7378 julesa@coreir.com

For investor inquiries: Scott Gordon for Alimera Sciences scottg@coreir.com

FAQ

When is Rick Eiswirth's presentation at the LD Micro virtual conference?

Rick Eiswirth's presentation is scheduled for April 15, 2021, at 11:00 AM ET.

What is the focus of Alimera Sciences?

Alimera Sciences specializes in developing prescription treatments for retinal diseases.

Where can I register for the LD Micro virtual conference?

Registration for the conference can be completed via the link provided in the press release.

What type of company is Alimera Sciences?

Alimera Sciences is a pharmaceutical company focused on ophthalmic pharmaceuticals.

Will there be opportunities for Q&A at the conference?

Yes, there will be a live Q&A session following Rick Eiswirth's presentation.